Impact of Metformin on Systemic Metabolism and Survival of Patients With Advanced Pancreatic Neuroendocrine Tumors

• Claudio Vernieri,
• Claudio Vernieri,
• Sara Pusceddu,
• Filippo de Braud,
• Filippo de Braud

Affiliations

Claudio Vernieri

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Claudio Vernieri

IFOM, The FIRC Institute of Molecular Oncology, Milan, Italy

Sara Pusceddu

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Filippo de Braud

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Filippo de Braud

Oncology and Hematology-Oncology Department, University of Milan, Milan, Italy